Roberto Boggio
Rome, 00071, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Phosphorylation of huntingtin at residue T3 is decreased in Huntington's disease and modulates mutant huntingtin protein conformation.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: November 23, 2017
Validation of Ultrasensitive Mutant Huntingtin Detection in Human Cerebrospinal Fluid by Single Molecule Counting Immunoassay.
Journal: Journal of Huntington's disease
Published: November 11, 2017
Quantifying autophagy using novel LC3B and p62 TR-FRET assays.
Journal: PloS one
Published: November 01, 2017
Synthesis, biological characterization and molecular modeling insights of spirochromanes as potent HDAC inhibitors.
Journal: European journal of medicinal chemistry
Published: August 04, 2015
Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington's disease patients.
Journal: The Journal of clinical investigation
Published: January 02, 2015
Polyglutamine- and temperature-dependent conformational rigidity in mutant huntingtin revealed by immunoassays and circular dichroism spectroscopy.
Journal: PloS one
Published: April 24, 2014
Chiral resolution and pharmacological characterization of the enantiomers of the Hsp90 inhibitor 2-amino-7-[4-fluoro-2-(3-pyridyl)phenyl]-4-methyl-7,8-dihydro-6H-quinazolin-5-one oxime.
Journal: ChemMedChem
Published: January 14, 2014
tert-Butylcarbamate-containing histone deacetylase inhibitors: apoptosis induction, cytodifferentiation, and antiproliferative activities in cancer cells.
Journal: ChemMedChem
Published: January 03, 2013
Synthesis and biological characterization of spiro[2H-(1,3)-benzoxazine-2,4'-piperidine] based histone deacetylase inhibitors.
Journal: European journal of medicinal chemistry
Published: November 30, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026